2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$8.07+$0.04 (+0.44%)
Price as of Sep 11, 2026 7:30 PM EDT- $36.6MMarket Cap
- 81.84%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$8.07+$0.04 (+0.44%)
HBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.03 | ||
Change | -$0.12 (-1.47%) | ||
Open | $8.18 | ||
High | $8.18 | ||
Low | $8.02 | ||
Previous Close | $8.15 | ||
Volume | 8,346 | ||
30-Day Average Volume | 21,423 | ||
1-Week Change | 0.12% | ||
1-Month Change | 31.00% | ||
1-Year Change | 81.84% | ||
3-Year Change | -80.70% | ||
5-Year Change | -89.60% | ||
Fundamentals | |||
Shares Outstanding | 4.6M | ||
Total Assets | $76.3M | ||
Market Cap | $36.6M | ||
Enterprise Value | $66.7M | ||
Period: QTR TTM FY | |||
Revenue | $22.7M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$363,000.00 | ||
EBIT | -$1.1M | ||
EBITDA | -$636,000.00 | ||
Net Working Capital | $21.7M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | -105 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 5 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -101 | ||
Price/Operating Cash Flow | 112 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue